糖尿病“尝起来”是什么样的?
What Does Diabetes "Taste" Like?
作者信息
Neiers Fabrice, Canivenc-Lavier Marie-Chantal, Briand Loïc
机构信息
Centre des Sciences du Goût et de l'Alimentation, INRA, CNRS, Université de Bourgogne - Franche-Comté, Dijon, 21000, France.
出版信息
Curr Diab Rep. 2016 Jun;16(6):49. doi: 10.1007/s11892-016-0746-2.
The T1R2 (taste type 1 receptor, member 2)/T1R3 (taste type 1 receptor, member 3) sweet taste receptor is expressed in taste buds on the tongue, where it allows the detection of energy-rich carbohydrates of food. This single receptor responds to all compounds perceived as sweet by humans, including natural sugars and natural and artificial sweeteners. Importantly, the T1R2/T1R3 sweet taste receptor is also expressed in extra-oral tissues, including the stomach, pancreas, gut, liver, and brain. Although its physiological role remains to be established in numerous organs, T1R2/T1R3 is suspected to be involved in the regulation of metabolic processes, such as sugar sensing, glucose homeostasis, and satiety hormone release. In this review, the physiological role of the sweet taste receptor in taste perception and metabolic regulation is discussed by focusing on dysfunctions leading to diabetes. Current knowledge of T1R2/T1R3 inhibitors making this receptor a promising therapeutic target for the treatment of type 2 diabetes is also summarized and discussed.
T1R2(味觉1型受体2成员)/T1R3(味觉1型受体3成员)甜味受体表达于舌头上的味蕾中,它使机体能够检测食物中富含能量的碳水化合物。这一单一受体对所有被人类感知为甜味的化合物均有反应,包括天然糖类以及天然和人工甜味剂。重要的是,T1R2/T1R3甜味受体也表达于口腔外组织,包括胃、胰腺、肠道、肝脏和大脑。尽管其在众多器官中的生理作用仍有待确定,但T1R2/T1R3被怀疑参与代谢过程的调节,如糖感知、葡萄糖稳态和饱腹感激素释放。在这篇综述中,通过聚焦导致糖尿病的功能障碍来讨论甜味受体在味觉感知和代谢调节中的生理作用。还总结并讨论了目前关于T1R2/T1R3抑制剂的知识,这些抑制剂使该受体成为治疗2型糖尿病的一个有前景的治疗靶点。